Lab Reagents

Bioss Antibodies Laboratories manufactures the biossusa bs-13642-r reagents distributed by Genprice. The Biossusa Bs-13642-R reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Bioss Antibodies. Other Biossusa products are available in stock. Specificity: Biossusa Category: Bs-13642-R

Test Assays information

R-7128
A3747-5 5 mg
EUR 548.4
Description: R-7128 is a selective nucleoside analog inhibitor of the hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase.

R-7128
A3747-5.1 10 mM (in 1mL DMSO)
EUR 597.6
Description: R-7128 is a selective nucleoside analog inhibitor of the hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase.

R-7128
A3747-50 50 mg
EUR 1794
Description: R-7128 is a selective nucleoside analog inhibitor of the hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase.

(R)-(+)-Atenolol
C3031-10 10 mg
EUR 393.6
Description: (R)-(+)-Atenolol is the less active enantiomer of the racemic ?1-adrenergic receptor antagonist, (R, S)-atenolol [1]. Atenolol is a selective ?1 receptor antagonist, a drug belonging to the group of beta blockers, a class of drugs used primarily in cardiovascular diseases.

(R)-(+)-Atenolol
C3031-25 25 mg
EUR 790.8
Description: (R)-(+)-Atenolol is the less active enantiomer of the racemic ?1-adrenergic receptor antagonist, (R, S)-atenolol [1]. Atenolol is a selective ?1 receptor antagonist, a drug belonging to the group of beta blockers, a class of drugs used primarily in cardiovascular diseases.

(R)-(+)-Atenolol
C3031-5 5 mg
EUR 247.2
Description: (R)-(+)-Atenolol is the less active enantiomer of the racemic ?1-adrenergic receptor antagonist, (R, S)-atenolol [1]. Atenolol is a selective ?1 receptor antagonist, a drug belonging to the group of beta blockers, a class of drugs used primarily in cardiovascular diseases.

R-7050
C3129-10 10 mg
EUR 268.8
Description: EC50: 0.631 ?M by TNF-? by ICAM-1 ELISA assayR-7050 is a TNF-? receptor signaling antagonist.TNF-? induces biological activity throgh stimulation of the tumor necrosis factor receptor.

R-7050
C3129-25 25 mg
EUR 477.6
Description: EC50: 0.631 ?M by TNF-? by ICAM-1 ELISA assayR-7050 is a TNF-? receptor signaling antagonist.TNF-? induces biological activity throgh stimulation of the tumor necrosis factor receptor.

R-7050
C3129-5 5 mg
EUR 184.8
Description: EC50: 0.631 ?M by TNF-? by ICAM-1 ELISA assayR-7050 is a TNF-? receptor signaling antagonist.TNF-? induces biological activity throgh stimulation of the tumor necrosis factor receptor.

(R)-Lisofylline
C4158-1 1 mg
EUR 154.8
Description: Lisofylline (LSF) is a potent anti-inflammatory agent. LSF is a chiral metabolite of pentoxifylline. (R)-LSF is the biologically active isomer of LSF [1].

(R)-Lisofylline
C4158-10 10 mg
EUR 822
Description: Lisofylline (LSF) is a potent anti-inflammatory agent. LSF is a chiral metabolite of pentoxifylline. (R)-LSF is the biologically active isomer of LSF [1].

(R)-Lisofylline
C4158-5 5 mg
EUR 489.6
Description: Lisofylline (LSF) is a potent anti-inflammatory agent. LSF is a chiral metabolite of pentoxifylline. (R)-LSF is the biologically active isomer of LSF [1].

Granuliberin R
5-01251 4 x 5mg Ask for price

Ranatensin R
5-01868 4 x 1mg Ask for price

(R)-Crizotinib
A3020-10 10 mg
EUR 129.6
Description: Crizotinib is a potent, ATP-competitive, small-molecule and orally available inhibitor of c-Met kinase with a Ki value of 4 nmol/L[1].Crizotinib has shown to inhibit wild-type c-Met phosphorylation with a mean IC50 value of 11 nmol/L in multiple human endothelial and carcinoma cell lines.

(R)-Crizotinib
A3020-100 100 mg
EUR 254.4
Description: Crizotinib is a potent, ATP-competitive, small-molecule and orally available inhibitor of c-Met kinase with a Ki value of 4 nmol/L[1].Crizotinib has shown to inhibit wild-type c-Met phosphorylation with a mean IC50 value of 11 nmol/L in multiple human endothelial and carcinoma cell lines.

(R)-Crizotinib
A3020-5.1 10 mM (in 1mL DMSO)
EUR 164.4
Description: Crizotinib is a potent, ATP-competitive, small-molecule and orally available inhibitor of c-Met kinase with a Ki value of 4 nmol/L[1].Crizotinib has shown to inhibit wild-type c-Met phosphorylation with a mean IC50 value of 11 nmol/L in multiple human endothelial and carcinoma cell lines.